Jump to content
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy
  • Project pages
    • MDR & IVDR
    • Innovation & Startups

BIOPRO BW Logo

Main navigation

  • Start page Start page
  • About us

    About us

    Close Close
    • Team
      • Our authors
    • History and achievements
    • Supervisory Board
    • Career
    • Contact / Travel information
  • Activities

    Activities

    Close Close
    • Start-up support
    • Cooperation initiatives
    • Anlaufstelle Regulatorik Gesundheitswirtschaft BW
  • Projects

    Projects

    Close Close
    • Current projects
      • Forum Health Region Baden-Württemberg
      • Advanced Imaging Utilization by Digital Data Application in Baden-Württemberg (PC3-AIDA)
      • Alliance for sustainable medical technology
      • The Phytopharmaceuticals and Valuable Plant Ingredients initiative
      • PRECISEU - PeRsonalised medicine Empowerment Connecting Innovation ecoSystems across EUrope
      • HACK-IT-NET - enabling an alpine region Health And Care Knowledge and Innovation Transfer NETwork
    • General Projects
      • EXI Start-Up Voucher
      • LinkHealth@BW
    • Completed projects
      • MDR & IVDR Fast-Track Support BW
      • Photon-Counting (PC)-CT Consortium
      • Health Data Scenarios
      • Baden-Württemberg-Center for Academic Drug Discovery
      • Post-Brexit
      • MDR & IVDR Competence Centre BW (MIK)
  • Services

    Services

    Close Close
    • Funding
    • Research institutions
    • Healthcare industry database
    • Job market
    • Newsletter
    • Stay in touch with us!
  • Information

    Information

    Close Close
    • Press releases & contact
    • Publications
  • Events

    Events

    Close Close
  • de
  • en
Show menu Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 09/02/2022

    Connecting fibres: The cellulose fibre industry impresses with innovation and vision

    The annual highlight of the industry is the International Conference on Cellulose Fibres in Cologne (www.cellulose-fibres.eu), where the latest innovations were showcased last week: new cellulose fibre technologies for various feedstocks and a wide range of hygiene and textile products as well as alternatives to plastics and carbon fibre for lightweight constructions.

    https://www.biooekonomie-bw.de/en/articles/pm/connecting-fibres-cellulose-fibre-industry-impresses-innovation-and-vision
  • Press release - 08/02/2022

    New European Research Council grant for Max Plack Researcher

    The European Research Council is funding a large-scale proof-of-concept study on a new genome sequencing method called “Haplotagging”. Haplotagging is a new method for sequencing our genome with superior quality and faster speed, developed by group leader Frank Chan and his team at the Friedrich Miescher Laboratory at the Max Planck Campus, Tübingen, Germany.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-european-research-council-grant-max-plack-researcher
  • Press release - 03/02/2022

    The 5G-OR Project is a Winner of the joint Franco-German Program for the Development of innovative Applications for 5G private Networks

    5G-OR is one of the 4 winning projects jointly selected by the Federal Ministry of Economics and Climate Action in Germany and the Ministry of Economy, Finance and Relaunch in France for the call “Technical developments and application ecosystems for 5G private networks”. The joint Franco-German 5G-OR project takes up the challenge in the healthcare domain.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/5g-or-project-winner-joint-franco-german-program-development-innovative-applications-5g-private-networks
  • Press release - 02/02/2022

    Animal Friends made of renewable resources

    fischertechnik has set a new milestone with the Animal Friends construction kit, as the building blocks and packaging are largely made of renewable resources and the models depict playful animals in new colours. The company is thereby taking another major step towards sustainability. The bio-based building set recently won the Toy Award, one of the most prestigious awards in the industry.

    https://www.biooekonomie-bw.de/en/articles/pm/animal-friends-aus-nachwachsenden-rohstoffen
  • Biosensor for whole blood and exhaled breath analysis - 02/02/2022 Nahaufnahme eines Multiplex-Chips mit roten oder blauen Kanälen, der zwischen zwei Fingern in blauen Handschuhen gehalten wird.

    Antibiotic detection from whole blood or exhaled breath possible

    Incorrectly dosed antibiotics are not only dangerous for patients, but also often the cause of resistant strains of bacteria. Researchers at the University of Freiburg have developed a biosensor to determine the effective amount and thus enable personalised therapy. The biosensor works by rapidly determining small amounts of the substances directly from whole blood or exhaled breath.

    https://www.gesundheitsindustrie-bw.de/en/article/news/antibiotic-detection-whole-blood-or-exhaled-breath-possible
  • Press release - 31/01/2022

    Cancer research learns from space travel

    Researchers use epigenetic factors to investigate the role of stress in the development of tumor diseases. Experts believe that stress plays a major role in the development of tumors. One occupational group, for example, that experiences extreme stress over a short period of time is astronauts.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/cancer-research-learns-space-travel
  • Press release - 28/01/2022

    New insights into predicting the efficacy of active ingredients in drug development

    Drugs consist of molecules developed in the drug laboratory that bind to their target, usually a protein, and thus exert their effect. The actual duration of binding of a drug molecule to its target protein varies depending on the drug. The lifetime of the drug-target complex can play a critical role in the efficacy of a drug, as a long residence time at the target can be crucial for the drug's action in some cases.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-insights-predicting-efficacy-active-ingredients-drug-development
  • Funding

    Venture Center of Excellence

    Funding programme, Funded by: EIT Health e.V. und European Investment Fund (EIF), sb_search.searchresult.label.programSubmissionDate: 31/12/2024
    https://www.gesundheitsindustrie-bw.de/en/database/funding/venture-center-excellence
  • Funding

    Venture Center of Excellence

    Funding programme, Funded by: EIT Health e.V. und European Investment Fund (EIF), sb_search.searchresult.label.programSubmissionDate: 31/12/2024
    https://www.gesundheitsindustrie-bw.de/en/database/funding/venture-center-excellence
  • Funding

    Venture Center of Excellence

    Funding programme, Funded by: EIT Health e.V. und European Investment Fund (EIF), sb_search.searchresult.label.programSubmissionDate: 31/12/2024
    https://www.bio-pro.de/en/service/funding/venture-center-excellence
  • Press release - 28/01/2022

    Artificial Muscles Made of Proteins

    Dr. Stefan Schiller and Dr. Matthias Huber from the University of Freiburg’s livMatS Cluster of Excellence have succeeded in developing a muscle solely on the basis of natural proteins. The autonomous contractions of the material, which the researchers presented in the journal Advanced Intelligent Systems, can be controlled with the help of pH and temperature changes.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/artificial-muscles-made-proteins
  • Viral zoonoses - 24/01/2022 Schematic drawing of a flavivirus polyprotein anchored in the ER membrane. The different viral proteins are indicated by differently coloured sections on the polyprotein that is marked with dashes and the protease interfaces are marked by arrows.

    Development of inhibitors that help stop viral zoonoses

    Emerging viral infections such as COVID-19 or Zika disease pose an increasing threat to humans. At the Institute of Pharmacy and Molecular Biotechnology (IPMB) at Heidelberg University, Prof. Dr. Christian Klein's research group is developing inhibitors against already known viruses in the hope that these can also be used against new virus variants.

    https://www.gesundheitsindustrie-bw.de/en/article/news/development-inhibitors-help-stop-viral-zoonoses
  • Press release - 18/01/2022

    Metal strip refiner HUEHOCO is a new shareholder of carbonauten and acquires 5 percent of the shares

    The HUEHOCO GROUP Holding GmbH & Co. KG, a family-owned company from Wuppertal, North Rhine-Westphalia, has acquired a 5 percent stake in carbonauten GmbH. The start-up is in negotiations with further interested parties from Germany and Japan. With the international metal strip refiner HUEHOCO Group, which has sites on 4 continents, the "minus CO2 factory" has acquired its first industrial partner.

    https://www.biooekonomie-bw.de/en/articles/pm/metal-strip-refiner-huehoco-new-shareholder-carbonauten-and-acquires-5-percent-shares
  • microRNA as a prognostic biomarker - 13/01/2022 Screen of an ECG device showing the typical action potentials of the heart muscle.

    Heart attack diagnosis: fast and unambiguous thanks to artificial intelligence

    People that arrive in emergency rooms with chest pain require swift action in order to rule out a heart attack or to initiate vital life-saving therapy. However, despite many advances, current tests are not yet optimal: they either take hours or produce false-positive results. Researchers at Heidelberg University Hospital are now using AI in an approach that takes microRNAs from a blood sample to specifically diagnose ‘acute coronary syndrome’.

    https://www.gesundheitsindustrie-bw.de/en/article/news/heart-attack-diagnosis-fast-and-unambiguous-thanks-artificial-intelligence
  • Press release - 13/01/2022

    Turning harmful CO2 into useful chemicals

    Making important raw materials for fine chemicals out of carbon dioxide really works. As part of the Max Planck collaborative project eBioCO2n, a team of researchers from Fraunhofer IGB have successfully performed a first ever fixation of CO2 via a multi-enzyme enzyme reaction driven by electricity yielding a prospective intermediate for the chemical industry. The process for electro-biocatalytic CO2 fixation was recently published and is…

    https://www.biooekonomie-bw.de/en/articles/pm/turning-harmful-co2-useful-chemicals
  • Protection against game damage - 13/01/2022 Nahaufnahme der beiden Holz-Modelle.

    Sapling protectors made of domestic wood - simple but effective

    Young forest plants need protecting against damage and as a result it’s often hard to miss the colourful plastic tree guard sleeves when out walking in forests. These tree guard sleeves are neither pleasing to the eye nor sustainable. Bernd Schairer UG from Albstadt has developed sapling protectors made of wood that contain no plastics, metals or chemicals, do not require removal and disposal, and are produced in a socially responsible way.

    https://www.biooekonomie-bw.de/en/articles/news/sapling-protectors-made-domestic-wood-simple-effective
  • Press release - 12/01/2022

    From insect carapace to sustainable building material

    Chitin is the main component of insect carapaces and ensures that they are both stable and flexible. The Chitinfluid research project, funded by the Carl Zeiss Foundation, focuses on the use of chitin in construction and aims to process chitin and its derivatives into sustainable materials. In a hybrid symposium under the auspices of Prof. Sabine Laschat from the University of Stuttgart, the project team discussed the current state of research…

    https://www.biooekonomie-bw.de/en/articles/pm/insect-carapace-sustainable-building-material
  • Press release - 11/01/2022

    Obesity at a young age - a risk factor for early colorectal cancer

    The incidence of colorectal cancers in young adults is increasing. At the same time, the proportion of overweight and obese young people is also on the rise. Whether there is a connection between these two observations, however, was not known until now. Scientists at the DKFZ have now shown that the risk of early colorectal cancer is significantly increased in overweight young people compared to normal-weight peers.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/obesity-young-age-risk-factor-early-colorectal-cancer
  • Press release - 10/01/2022

    Algorithm identifies cancer drivers

    Genetic alterations that promote the development and spread of tumors are difficult to identify. This is especially true for mutations in the non-protein-coding regions of the genome, which include all important regulatory sequences. Scientists at the German Cancer Research Center have now published an algorithm that detects cancer drivers in both the protein-coding and non-coding regions of the genome.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/algorithm-identifies-cancer-drivers
  • Press release - 21/12/2021

    Cochlear implant as a sensor

    The cochlear implant (CI) is the most successful neural prosthesis worldwide. Thanks to direct stimulation of the auditory nerve, it enables more than half a million people worldwide to hear, even though those affected were born deaf or deafened.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/cochlear-implant-sensor
  • Press release - 20/12/2021

    Immune microenvironment as a risk factor for colorectal cancer in Lynch syndrome

    Researchers at Heidelberg University Hospital (UKHD), the German Cancer Research Center (DKFZ) and at the National Center for Tumor Diseases (NCT) Heidelberg have demonstrated for the first time that there is a link between the development of colorectal cancer in individuals with Lynch syndrome and the composition of immune cells in the colorectal mucosa.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/immune-microenvironment-risk-factor-colorectal-cancer-lynch-syndrome
  • Press release - 18/12/2021

    WHO publishes first classification of childhood tumors

    The International Agency for Research on Cancer (IARC), an agency of the World Health Organization (WHO), will soon publish the first edition of its classification of childhood cancers. The new WHO classification forms the basis of modern, precise cancer diagnostics for physicians and pediatric oncologists worldwide and is based on the latest international research findings.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/who-publishes-first-classification-childhood-tumors
  • Dossier - 16/12/2021 In-vivo-Gentherapien wie Zolgensma und Ex-vivo-Gentherapien wie CAR-T-Zellen.

    Advanced therapy medicinal products: gene and cell therapies

    Novel gene and cell therapies for treating incurable and hereditary diseases have raised high expectations. However, success has so far been limited to the long-established bone marrow transplants involving the administration of haematopoietic stem cells used to treat blood cancer. CAR T-cell therapies have recently emerged as a major new hope in cancer treatment.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/advanced-therapy-medicinal-products-gene-and-cell-therapies
  • Press release - 14/12/2021

    Carbon fibres from wood - DITF nomination for the "Cellulose Fibre Innovation of the Year" award

    For the second time, the nova Institute for Ecology and Innovation is honouring outstanding scientific research that provides sustainable solutions for the cellulose fibre value chain as part of the "International Conference on Cellulose Fibres 2022". The DITF Denkendorf is one of the six nominees.

    https://www.biooekonomie-bw.de/en/articles/pm/carbon-fibres-wood-ditf-nomination-cellulose-fibre-innovation-year-award

Page 26 / 48

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 48
  • eine Seite zurück
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • About us
    • Team
    • History and achievements
    • Supervisory Board
    • Career
    • Contact / Travel information
  • Activities
    • Start-up support
    • Cooperation initiatives
    • Anlaufstelle Regulatorik Gesundheitswirtschaft BW
  • Projects
    • Current projects
    • General Projects
    • Completed projects
  • Services
    • Funding
    • Research institutions
    • Healthcare industry database
    • Job market
    • Newsletter
    • Stay in touch with us!
  • Information
    • Press releases & contact
    • Publications
  • Events
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Newsletter abonnieren

Social Media

  • Xing Xing
  • Twitter visit Twitter
  • LinkedIn visit LinkedIn
  • Rss visit RSS
  • Privacy statement
  • Accessability Declaration
  • Legal notice
  • Sitemap
  • Contact
© 2025
Website address: https://www.bio-pro.de/en/search